Advisor Group Holdings, Inc. Biomarin Pharmaceutical Inc Transaction History

Advisor Group Holdings, Inc.

  • $42.2 Billion
  • Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 3,465 shares of BMRN stock, worth $213,894. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,465
Previous 4,680 25.96%
Holding current value
$213,894
Previous $385,000 36.88%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$69.02 - $93.84 $83,859 - $114,015
-1,215 Reduced 25.96%
3,465 $243,000
Q2 2024

Aug 13, 2024
SELL
$74.43 - $92.22 $136,504 - $169,131
-1,834 Reduced 28.15%
4,680 $385,000
Q1 2024

May 10, 2024
SELL
$83.81 - $99.0 $1.14 Million - $1.35 Million
-13,597 Reduced 67.61%
6,514 $568,000
Q4 2023

Feb 12, 2024
SELL
$76.22 - $98.51 $265,321 - $342,913
-3,481 Reduced 14.76%
20,111 $1.94 Million
Q3 2023

Nov 13, 2023
BUY
$85.07 - $94.48 $687,110 - $763,114
8,077 Added 52.06%
23,592 $2.09 Million
Q2 2023

Aug 10, 2023
SELL
$86.68 - $100.3 $226,668 - $262,284
-2,615 Reduced 14.42%
15,515 $1.34 Million
Q1 2023

May 12, 2023
BUY
$87.74 - $117.27 $68,788 - $91,939
784 Added 4.52%
18,130 $1.76 Million
Q4 2022

Feb 10, 2023
SELL
$80.93 - $108.63 $14,324 - $19,227
-177 Reduced 1.01%
17,346 $1.8 Million
Q3 2022

Nov 14, 2022
SELL
$82.16 - $96.94 $19,471 - $22,974
-237 Reduced 1.33%
17,523 $1.49 Million
Q2 2022

Aug 10, 2022
SELL
$71.48 - $86.85 $273,553 - $332,374
-3,827 Reduced 17.73%
17,760 $1.47 Million
Q1 2022

May 04, 2022
SELL
$74.28 - $92.69 $160,593 - $200,395
-2,162 Reduced 9.1%
21,587 $1.64 Million
Q3 2021

Nov 05, 2021
BUY
$74.77 - $85.47 $25,571 - $29,230
342 Added 1.46%
23,749 $1.84 Million
Q2 2021

Aug 02, 2021
BUY
$75.51 - $84.79 $85,024 - $95,473
1,126 Added 5.05%
23,407 $1.95 Million
Q1 2021

May 13, 2021
BUY
$74.73 - $90.69 $248,477 - $301,544
3,325 Added 17.54%
22,281 $1.67 Million
Q4 2020

Feb 10, 2021
BUY
$72.61 - $90.2 $192,053 - $238,579
2,645 Added 16.22%
18,956 $1.66 Million
Q3 2020

Nov 12, 2020
SELL
$71.87 - $131.03 $214,747 - $391,517
-2,988 Reduced 15.48%
16,311 $1.25 Million
Q2 2020

Aug 14, 2020
BUY
$79.55 - $124.22 $313,188 - $489,054
3,937 Added 25.63%
19,299 $2.38 Million
Q1 2020

May 18, 2020
BUY
$71.37 - $96.85 $1.1 Million - $1.49 Million
15,362 New
15,362 $1.3 Million

Others Institutions Holding BMRN

# of Institutions
641
Shares Held
178M
Call Options Held
2M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $11.5B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email